Identifying oral cancer early | British Dental Journal

Oral cancer is both prevalent and fatal, with late diagnosis needing aggressive treatments that have a slimmer chance of success. Identifying oral cancer early is imperative to beating it.

The biomarkers associated with oral cancer risk can be detected by the BeVigilant OraFusion System from Vigilant Biosciences. The innovative technology provides simple and accurate

assessments of the patient's risk level - low, moderate or high risk - generating a ‘Monitor' or ‘Investigate Further' prompt. Supporting the level of early intervention that

can successfully treat cancer, the BeVigilant OraFusion System is easy to set-up and use, with results available in 15 minutes or fewer. This fast turnaround allows practitioners and

patients to discuss the results and what to do next within the same appointment. Being able to do a quick test can better confirm the risk of a patient developing oral cancer. With the

BeVigilant OraFusion System, oral cancer can be detected early. For more information, visit www.vigilantbiosciences.com or email [email protected]. RIGHTS AND PERMISSIONS Reprints

and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Identifying oral cancer early. _Br Dent J_ 237, 571 (2024). https://doi.org/10.1038/s41415-024-7990-7 Download citation * Published: 11

October 2024 * Issue Date: 11 October 2024 * DOI: https://doi.org/10.1038/s41415-024-7990-7 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get

shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative